<div class="card">
  <img src="https://bloximages.chicago2.vip.townnews.com/dailyrepublic.com/content/tncms/assets/v3/editorial/4/7e/47e1e6c7-552e-5fb2-b859-638101d393f2/68625b6f01356.image.jpg?resize=300%2C186" alt="Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms" style="width:100%; height:180px; object-fit:cover; border-radius:5px;">
  <div style="padding:10px">
    <h3>Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms</h3>
    <p>SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major...</p>
    <a href="https://www.dailyrepublic.com/online_features/press_releases/innovent-biologics-showcases-dual-innovations-at-oncology-r-d-day-pioneering-the-future-of-cancer/article_60080f2c-e971-5f43-85ff-487e81991f66.html" target="_blank" style="color:red">Read More â†’</a>
  </div>
</div>

